Paul Tabor is currently the associate director of licensing, after joining CU Innovations as a licensing associate in 2008. He is responsible for evaluating CU invention disclosures, negotiating option and license agreements, and working with inventors and industry professionals to successfully commercialize new technologies impacting human health.
Prior to joining CU Tech Transfer, Paul worked with pharmaceutical and venture capital clients to evaluate the commercial potential of acquisition and in-licensing targets. He managed both market research and business development projects and made investment recommendations concerning new biomedical technologies. Paul also spent several years as a research scientist at Baylor College of Medicine’s Human Genome Sequencing Center. His work on the Human Genome Project advanced knowledge of human chromosomes X and 12, and he also collaborated with UC Berkeley on the Drosophila Genome Project. His work is published in journals such as Nature and Science.
Paul earned a MBA in Finance from the University of Texas at Austin, a Master of Clinical Gerontology from Baylor University, and a B.A. in Chemistry and Biology from Baylor University.